Freeman Capital Management | Activist Presentation Deck | 95 slides · page 29 of 95
Two-column layout: left side has line illustration of clinical documents (vial, briefcase, paper); right side stacks claim label, FCM analysis, highlighted finding callout, and IIT study commentary. Source citation '[11], [12]' bottom-left.
Activist deck · expose_contradiction · expose_contradiction · overcrowded density
Slide locked Sign in to view
Slide schematic 9/9
callout 2/2 image 1/1 paragraph 3/3 source-note 1/1 title 2/2
Components 9
primary primary illustration paragraph paragraph paragraph source-note action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 3
Authority citation 75%
Footnote references [11], [12] grounding the claim in cited sources; FDA and NINDS invoked as authorities.
Comparison frame 85%Slide juxtaposes MindMed's claim against FCM's data analysis to invalidate it.
Quantification 90%Specific figures cited: 62 drugs analyzed, 66% used Phase III dose finding, 2012-April 2023 window.